2591 - 2600 of 7916 Results
Title
Year
-
RESTRICTEDTitle: Serotonergic and Dopaminergic Lesions Underlying Parkinsonian Neuropsychiatric SignsJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 12Start Page: 2888End Page: 2900Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28722Citation Count: 46
- Subcutaneous Levodopa Infusion for Parkinson's Disease: 1‐Year Data from the Open‐Label BeyoND Study2021OPENTitle: Subcutaneous Levodopa Infusion for Parkinson's Disease: 1‐Year Data from the Open‐Label BeyoND StudyJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 11Start Page: 2687End Page: 2692Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28758Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28758Citation Count: 26
-
OPENTitle: Altered Brain Functional Network in Subtypes of Parkinson's Disease: A Dynamic PerspectiveJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2021.710735Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2021.710735/pdfCitation Count: 20
-
OPENTitle: Heterogeneity of prodromal Parkinson symptoms in siblings of Parkinson disease patientsJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-021-00219-1Best OA location URL: https://www.nature.com/articles/s41531-021-00219-1.pdfCitation Count: 2
-
OPENTitle: Psychometric properties of the Beck Depression Inventory‐II in progressive supranuclear palsyJournal Name: Brain and BehaviorPublisher: WileyVol: 11Issue #: 10Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/brb3.2344Best OA location URL: https://europepmc.org/articles/pmc8553313?pdf=renderCitation Count: 10
-
OPENTitle: Classification based levodopamine response prediction in parkinson’s disorderJournal Name: Applied Artificial IntelligencePublisher: Informa UK LimitedVol: 35Issue #: 15Start Page: 1287End Page: 1303Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1080/08839514.2021.1975881Best OA location URL: https://www.tandfonline.com/doi/pdf/10.1080/08839514.2021.1975881?needAccess=trueCitation Count: 1
- Subthalamic and pallidal deep brain stimulation for Parkinson’s disease—meta-analysis of outcomes2021OPENTitle: Subthalamic and pallidal deep brain stimulation for Parkinson’s disease—meta-analysis of outcomesJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-021-00223-5Best OA location URL: https://www.nature.com/articles/s41531-021-00223-5.pdfCitation Count: 66
- Epigenomic features related to microglia are associated with attenuated effect of APOE ε4 on Alzheimer's disease risk in humans2021RESTRICTEDTitle: Epigenomic features related to microglia are associated with attenuated effect of APOE ε4 on Alzheimer's disease risk in humansJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 18Issue #: 4Start Page: 688End Page: 699Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/alz.12425Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9475136Citation Count: 9
-
OPENTitle: Neurofilament Light Chain as a Biomarker for Cognitive Decline in Parkinson DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 12Start Page: 2945End Page: 2950Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28779Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8688198Citation Count: 90
- Leukotriene receptor antagonist use and cognitive decline in normal cognition, mild cognitive impairment, and Alzheimer’s dementia2021OPENTitle: Leukotriene receptor antagonist use and cognitive decline in normal cognition, mild cognitive impairment, and Alzheimer’s dementiaJournal Name: Alzheimer's Research & TherapyPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13195-021-00892-7Best OA location URL: https://alzres.biomedcentral.com/counter/pdf/10.1186/s13195-021-00892-7Citation Count: 15